​​Hockey Mom Foundation
The Hockey Mom Foundation is an all volunteer organization that honors Hockey Moms everywhere by raising funds to make one time foundational donations to non-profits focused on furthering cancer research, and the care of cancer patients.
Register Is Open!
Friday, September 13, 2024, Glen Oak Golf Club, East Amherst, NY
Click the Gator for information/registration
December 2023 grant of $25,000 for CarT research at Roswell
Kevin Weber, Al, and I were blessed to represent your generosity and present the check to Amanda Berg of the Roswell Park Alliance Foundation. CAR T-cell therapy clinical trials are seeing improvement in survival rates for patients with blood cancers. With those achievements in mind, the team at Roswell Park is now shifting their focus to using their technology and discoveries to study CAR T-cell therapy on solid tumors like breast, lung, pediatrics, prostate and more. Dr. Brentjens is actively working on two clinical trials, which look to improve CAR T-cell therapy. Those trials are in very early stages, but could bring about groundbreaking changes to the way cancer is treated.
In February of 2022, Hockey Mom Foundation presented a $25,000 grant
to Roswell Park Cancer Institutefor a very promising pediatric drug trial called Curaxin.
With a successful trial, the benefits could be amazing for children with pediatric cancers. The favorable safety profile of Curaxin is boosted by the unique mechanism of action and these results support strong expectations for Curaxin’s success in the pediatric oncology arena. Dr. Katerina Gurova leads the Curaxin pediatric research at Roswell and we had the pleasure of meeting her during our check presentation. She shared that, of late, children primarily receive adult chemotherapy treatments. These treatments are tough on adults, and even more painful for children. As one would expect given the enormous risks to children, pediatric trials are very difficult and expensive to administer. The National Cancer Institute’s Children’s Oncology Group (COG), the most reputable organization in the US that coordinates
international clinical trials for pediatric cancer patients, selected Curaxin for a multicenter clinical study
We celebrated Mother's Day 2021 by presenting a $10,000 grant to Roswell Park Alliance Foundation to help advance the testing of a promising vaccine called SurVax M in glioblastoma patients.
With our very first grant In 2015, the HMF helped fund phase I clinical study of a peptide vaccine called SurVax M, and the great majority of the patients who received all doses of the vaccine – all of whom had failed standard therapy – survived longer than a year. In some cases, patients are still alive today, more than 5 years after they started treatment with SurVaxM. “In a disease where few survive beyond eight months, that’s an important signal,” said Dr. Fenstermaker, vaccine pioneer.
​
Roswell is now well into the first step of the phase II clinical trial, with SurVaxM undergoing testing in patients with newly diagnosed glioblastoma brain tumors. Now that this step has proven both successful and safe, it’s time for the critical second step in this phase, a larger randomized trial that will be available to patients at 20 other cancer centers across the country. The HMF is thrilled to grant Roswell Park with additional funds to further this next step.
The HMF granted $10,000 to Cleveland Clinic Gynecologic Oncology Research Program on December 12, 2019
Gynecologic cancers, including endometrial and ovarian cancers, are a leading cause of cancer-related deaths in women. The ability of gynecologic tumors to adapt to and evade treatment is a major factor contributing to the poor outcomes that many patients face. The goal of the Cleveland Clinic Gynecologic Oncology Research Program is to explore possible causes of, and treatments for, a range of gynecologic cancers and identify breakthroughs to overcome resistance to current treatment strategies, while also focusing on the advances most needed by patients, now.
On Friday, April 12th, the Hockey Mom Foundation presented $10,000 to Dr. Kara Kelly, Chair of the Department of Pediatric Oncology at Roswell Park Comprehensive Cancer Center, Buffalo, New York.
We are pleased to support Roswell's Phase 1 study of the use of the SurVaxM vaccine in pediatric patients with relapsed or refractory Medulloblastoma or High Grade Glioma (HGG). This trial is expected to be opened by June 2019, and will be offered at numerous children’s hospitals across the country.
​
On April 12th, 2018 the Hockey Mom Foundation granted $10,000 to Dr. Charis Eng's breast cancer research at Cleveland Clinic's Lerner Research Institute. We are thrilled to support her groundbreaking work using nanoparticles to change the behavior of tumor microbes and treat breast cancer.
Buffalo, New York's soon to open
John R. Oishei Children's Hospital
Hematology & Oncology Unit received our
August 30, 2016, Hockey Mom Foundation Board Members and Volunteers present a $5000 donation to the Cleveland Clinic Taussig Cancer Institute
for Patient Support Services (read more)
Duke’s mother, Ruth, traveled across the country and Canada in support of her three sons, who all grew up playing hockey. Ruth was also a member of a group of hockey moms in Buffalo who called themselves “The Gators.” Along with Ruth Duke, the group comprised Judy Rechan, Jane Opre, Liz Carone and Barbara Brown. (read more)
The HOCKEY Mom Foundation...
supporting cancer research, education for hockey players
by ANNA WALTERS Reporter
Off the ice, a hockey mom is her child’s biggest defender. She supports his or her endeavors and passion for the game. John Duke witnessed his mother’s sacrifices, from traveling long distances to time spent sitting in the stands.
